Stephen Willey
Stock Analyst at Stifel
(2.33)
# 2,506
Out of 4,869 analysts
130
Total ratings
39.18%
Success rate
-0.03%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stephen Willey
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| INCY Incyte | Upgrades: Buy | $75 → $107 | $68.46 | +56.30% | 6 | Jun 16, 2025 | |
| MGNX MacroGenics | Maintains: Hold | $6 → $5 | $1.31 | +281.68% | 3 | May 14, 2025 | |
| EXEL Exelixis | Maintains: Hold | $36 → $38 | $40.37 | -5.87% | 18 | May 14, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Hold | $25 → $20 | $5.79 | +245.42% | 4 | May 13, 2025 | |
| NRIX Nurix Therapeutics | Maintains: Buy | $36 → $35 | $11.48 | +204.88% | 5 | Apr 9, 2025 | |
| NKTX Nkarta | Maintains: Buy | $15 → $14 | $1.77 | +690.96% | 3 | Mar 27, 2025 | |
| VOR Vor Biopharma | Maintains: Buy | $12 → $5 | $0.24 | +1,980.73% | 5 | Mar 21, 2025 | |
| ABCL AbCellera Biologics | Maintains: Buy | $12 → $10 | $3.41 | +193.26% | 5 | Feb 28, 2025 | |
| GERN Geron | Maintains: Buy | $8 → $4 | $1.51 | +164.90% | 3 | Feb 27, 2025 | |
| INSM Insmed | Maintains: Buy | $97 → $96 | $102.68 | -6.51% | 6 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $27 → $2.5 | $1.17 | +113.68% | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $120 | $2.67 | +4,394.38% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $28 | $12.48 | +124.36% | 6 | Oct 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $47 | $9.32 | +404.29% | 1 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $8 → $4 | $0.70 | +470.86% | 7 | Aug 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $34 → $3 | $1.86 | +61.29% | 3 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $7 | $2.26 | +209.73% | 10 | Apr 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $1.65 | +142.42% | 1 | Dec 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $53 → $62 | $32.06 | +93.39% | 5 | Dec 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.40 | +275.00% | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $1.59 | +654.72% | 1 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $228 → $288 | $1.96 | +14,593.88% | 4 | Jun 26, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $21 | $3.02 | +595.36% | 2 | Mar 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $10 → $4 | $0.75 | +433.33% | 7 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $125 → $123 | $309.70 | -60.28% | 3 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $48 → $47 | $37.41 | +25.63% | 2 | Aug 8, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $102 → $109 | $55.00 | +98.18% | 3 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Terminates: Hold | n/a | $21.00 | - | 2 | Jun 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $23 | $7.40 | +210.81% | 5 | Feb 7, 2018 |
Incyte
Jun 16, 2025
Upgrades: Buy
Price Target: $75 → $107
Current: $68.46
Upside: +56.30%
MacroGenics
May 14, 2025
Maintains: Hold
Price Target: $6 → $5
Current: $1.31
Upside: +281.68%
Exelixis
May 14, 2025
Maintains: Hold
Price Target: $36 → $38
Current: $40.37
Upside: -5.87%
Bolt Biotherapeutics
May 13, 2025
Maintains: Hold
Price Target: $25 → $20
Current: $5.79
Upside: +245.42%
Nurix Therapeutics
Apr 9, 2025
Maintains: Buy
Price Target: $36 → $35
Current: $11.48
Upside: +204.88%
Nkarta
Mar 27, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $1.77
Upside: +690.96%
Vor Biopharma
Mar 21, 2025
Maintains: Buy
Price Target: $12 → $5
Current: $0.24
Upside: +1,980.73%
AbCellera Biologics
Feb 28, 2025
Maintains: Buy
Price Target: $12 → $10
Current: $3.41
Upside: +193.26%
Geron
Feb 27, 2025
Maintains: Buy
Price Target: $8 → $4
Current: $1.51
Upside: +164.90%
Insmed
Feb 21, 2025
Maintains: Buy
Price Target: $97 → $96
Current: $102.68
Upside: -6.51%
Jan 10, 2025
Downgrades: Hold
Price Target: $27 → $2.5
Current: $1.17
Upside: +113.68%
Nov 14, 2024
Maintains: Buy
Price Target: $150 → $120
Current: $2.67
Upside: +4,394.38%
Oct 28, 2024
Maintains: Buy
Price Target: $21 → $28
Current: $12.48
Upside: +124.36%
Oct 8, 2024
Initiates: Buy
Price Target: $47
Current: $9.32
Upside: +404.29%
Aug 20, 2024
Maintains: Buy
Price Target: $8 → $4
Current: $0.70
Upside: +470.86%
Jul 9, 2024
Downgrades: Hold
Price Target: $34 → $3
Current: $1.86
Upside: +61.29%
Apr 12, 2024
Maintains: Hold
Price Target: $7
Current: $2.26
Upside: +209.73%
Dec 19, 2023
Maintains: Buy
Price Target: $3 → $4
Current: $1.65
Upside: +142.42%
Dec 18, 2023
Maintains: Buy
Price Target: $53 → $62
Current: $32.06
Upside: +93.39%
Jan 27, 2023
Initiates: Buy
Price Target: $9
Current: $2.40
Upside: +275.00%
Nov 28, 2022
Initiates: Buy
Price Target: $12
Current: $1.59
Upside: +654.72%
Jun 26, 2020
Downgrades: Hold
Price Target: $228 → $288
Current: $1.96
Upside: +14,593.88%
Mar 17, 2020
Maintains: Buy
Price Target: $22 → $21
Current: $3.02
Upside: +595.36%
Jul 29, 2019
Downgrades: Hold
Price Target: $10 → $4
Current: $0.75
Upside: +433.33%
Aug 13, 2018
Maintains: Buy
Price Target: $125 → $123
Current: $309.70
Upside: -60.28%
Aug 8, 2018
Maintains: Hold
Price Target: $48 → $47
Current: $37.41
Upside: +25.63%
Aug 3, 2018
Maintains: Buy
Price Target: $102 → $109
Current: $55.00
Upside: +98.18%
Jun 25, 2018
Terminates: Hold
Price Target: n/a
Current: $21.00
Upside: -
Feb 7, 2018
Maintains: Buy
Price Target: $20 → $23
Current: $7.40
Upside: +210.81%